Funding for this research was provided by:
National Natural Science Foundation of China (81830005)
National Basic Research Program of China (973 Program) (2019YFA0110204)
CAMS Innovation Fund for Medical Sciences (CIFMS 2016-I2M-1-007)
Received: 4 May 2020
Accepted: 17 August 2020
First Online: 7 September 2020
Ethics approval and consent to participate
: This research was approved by the ethical committee in the Institute of Hematology and Blood Diseases Hospital, and all procedures were in accordance with the Helsinki Declaration. Written informed consent was obtained from each participant, in which the informed consent of pediatric patients was provided by their parents or guardians.
: Not applicable
: Jianxiang Wang received grant from Celgene. The other authors declare that they have no conflict of interest.